Yano, Yukiko
Abnet, Christian C.
Roshandel, Gholamreza
Graf, Akua
Poustchi, Hossein
Khoshnia, Masoud
Pourshams, Akram
Kamangar, Farin
Boffetta, Paolo
Brennan, Paul
Dawsey, Sanford M.
Vogtmann, Emily
Malekzadeh, Reza
Etemadi, Arash
Funding for this research was provided by:
Division of Cancer Epidemiology and Genetics, National Cancer Institute (Intramural Research Program of the National Cancer Institute)
Tehran University of Medical Sciences and Health Services (81/15)
Cancer Research UK (C20/ A5860)
Article History
Received: 8 November 2023
Accepted: 6 January 2024
First Online: 13 January 2024
Declarations
:
: Written informed consent was obtained from all study participants at the time of enrollment. The Golestan Cohort Study was approved by the Institutional Review Boards of the Digestive Disease Research Institute of Tehran University of Medical Sciences, the International Agency for Research on Cancer, and the United States National Cancer Institute.
: Not applicable.
: The authors declare no competing interests.